The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?

In-House Versus Outsource: A Decision-Making Guide

Whitepaper

The biologics market is quickly evolving from a focus on developing blockbuster drugs to exploring niche markets with unmet needs. While the changes are exciting, they pose several risks to a molecule’s success as competition intensifies, timelines shorten and capacity challenges emerge. Yesterday’s solutions may not be a perfect fit for today’s molecules.

Authors:
Barry Rosenblatt, PhD President, SME Biotech Consulting
Dave Kenyon, PhD Vice President, Process Sciences Pharma Services Patheon, by Thermo Fisher Scientific